-
Ramipril (Altace) is a long-acting oral angiotensin-converting enzyme (ACE) inhibitor indicated for the treatment of patients with essential hypertension or congestive heart failure after myocardial infarction. Ramipril also is indicated in cardiovascular risk reduction.
-
-
Whether a bite or sting results in an anaphylactic reaction, impressive
local effects, or a life-threatening systemic reaction, the emergency
physician must be able to institute appropriate and effective
treatment. Emergency physicians also must be able to recognize clinical
envenomation patterns, since some critically ill patients may not be
able to convey the details of the attack. Since all areas of the
country are represented in the envenomation statistics, all emergency
physicians should be familiar with identification and stabilization of
envenomated patients and know what resources are available locally for
further management of these often complicated patients.
-
-
This background on cerebral palsy and summary of the new findings was provided by the American College of Obstetricians and Gynecologists.
-
Though it has been common in many health care institutions for decades, the practice of medical students and residents performing pelvic exams on women who have been anesthetized for surgery, without any medical need, and usually without consent is increasingly coming under fire from critics who say it just isnt right.
-
In a move that will add one more regulatory concern to the risk managers plate, the Occupational Safety and Health Administration (OSHA) recently issued the first in a series of industry-specific guidelines for the prevention of musculoskeletal disorders in the workplace. Its target: nursing homes.
-
One summer evening, fire ants attacked a 79-year-old nursing home patient resident as she lay in her bed. Because of the severe bites, she developed a staphylococcal infection and and the trauma further exacerbated her dementia.
-
-
A recently issued report will be a boon to defendants in cerebral palsy malpractice cases, but it wont eliminate this brand of high-dollar cases or create an insurmountable burden for plaintiffs attorneys, experts say.
